跳至主要内容
临床试验/NCT01489852
NCT01489852已完成4 期

Interest of a Steroid Pre-treatment Prior to IVF Protocol With Ovarian Stimulation by Recombinant FSH and With LH Surge Blockage by Daily GnRH Antagonist

Gemer1 个研究点 分布在 1 个国家目标入组 472 人开始时间: 2006年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
472
试验地点
1
主要终点
number of retrieved oocytes

研究概览

简要总结

The purpose of this study is to assess whether estrogen pre-treatment can allow retrieval of 2 additional oocytes in GnRH antagonist protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 38 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • regular normo-ovulatory cycles (28 to 35 days)
  • age < 38 years,
  • body mass index (BMI) between 18 and 30
  • first or second IVF/ICSI attempt

排除标准

  • high basal levels of serum FSH or E2,
  • less than 5 follicles at the antral follicular count performed on day 3 of a spontaneous cycle,
  • history of high (>20 oocytes) or low (< 5 oocytes) ovarian response in a previous IVF attempt

研究组 & 干预措施

Estrogen pre-treatment

Active Comparator

干预措施: 17beta-estradiol (Drug)

结局指标

主要结局

number of retrieved oocytes

时间窗: at the ovarian puncture, 36 hours post HCG administration

次要结局

  • delivery rate(9 months later)
  • number of obtained embryos(2 days after in vitro fertilization)
  • pregnancy rate(at pregnancy test and at 6 Week US examination)
  • duration of FSH administration(at the end of ovarian stimulation usually after a mean of 12 days of administration)
  • Total FSH dose(at the end of ovarian stimulation usually after a mean of 12 days of administration)

研究者

发起方
Gemer
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr CEDRIN-DURNERIN Isabelle

principal investigator

Gemer

研究点 (1)

Loading locations...

相似试验

Estrogen Pretreatment Prior to GnRH Antagonist... | 临床试验